(Q36006317)

11 August 2017

Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer (English)

1 reference

11 August 2017

Samuel Swisher-McClure

object named as

Samuel Swisher-McClure

1

0 references

Thomas J Guzzo

4

object named as

Thomas J Guzzo

1 reference

11 August 2017

John P Christodouleas

3

object named as

John P Christodouleas

1 reference

11 August 2017

Craig E Pollack

2

1 reference

11 August 2017

Naomi B Haas

5

1 reference

11 August 2017

Neha Vapiwala

6

1 reference

11 August 2017

Justin E Bekelman

7

1 reference

11 August 2017

language of work or name

English

0 references

publication date

11 November 2011

1 reference

International Journal of Radiation Oncology Biology Physics

11 August 2017

1 reference

11 August 2017

83

1 reference

11 August 2017

1

1 reference

11 August 2017

8-15

1 reference

Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366632

Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366632

Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366632

Reimbursement issues with hormonal therapies for prostate cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366632

Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366632

6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366632

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366632

Comorbidity measures for use with administrative data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366632

Reimbursement policy and androgen-deprivation therapy for prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366632

Radiation with or without 6 months of androgen suppression therapy in intermediate- and high-risk clinically localized prostate cancer: a postrandomization analysis by risk group

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366632

Androgen deprivation falls as orchiectomy rates rise after changes in reimbursement in the U.S. Medicare population.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366632

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366632

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366632

Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366632

Survival associated with treatment vs observation of localized prostate cancer in elderly men

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22079721

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22079721

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22079721

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.IJROBP.2011.06.1951

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22079721

1 reference